From: Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
KRAS | BRAF | MSI | OPN | SASH1 | MACC1 | CD3 | ||
---|---|---|---|---|---|---|---|---|
BRAF | c.coeff. | −0.243 | ||||||
p | 0.034 | |||||||
MSI-H | c.coeff. | −0.197 | 0.646 | |||||
p | 0.098 | < 0.001 | ||||||
OPN | c.coeff. | 0.021 | 0.177 | 0.208 | ||||
p | 0.858 | 0.127 | 0.08 | |||||
SASH1 | c.coeff. | −0.115 | 0.012 | − 0.007 | 0.288 | |||
p | 0.324 | 0.921 | 0.956 | 0.012 | ||||
MACC1 | c.coeff. | 0.127 | −0.118 | −0.163 | −0.013 | 0.237 | ||
p | 0.272 | 0.311 | 0.171 | 0.909 | 0.039 | |||
CD3 | c.coeff. | −0.002 | 0.179 | 0.08 | −0.277 | −0.203 | − 0.047 | |
p | 0.989 | 0.121 | 0.504 | 0.015 | 0.078 | 0.69 | ||
CD8 | c.coeff. | 0.072 | 0.198 | 0.177 | −0.244 | −0.078 | −0.044 | 0.749 |
p | 0.536 | 0.086 | 0.137 | 0.034 | 0.505 | 0.709 | < 0.001 |